Back to News
Market Impact: 0.2
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
Source: zacks.com
Analyst InsightsCorporate Guidance & OutlookHealthcare & Biotech
Oscar Health (OSCR) was upgraded to Zacks Rank #1 (Strong Buy) on improving optimism around its earnings outlook. The upgrade could support near-term share-price upside, though the article provides no underlying earnings estimates or financial figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
OSCR0.75
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- US aviation sanctions disrupt Iran flights, push travellers overland
- Australia says OpenAI agent hacked Medicare portal
- Meta's standoff with Amazon over Muse could be a sign of things to come
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’